Replies to post #29278 on EP Global Communications Inc fka EPGL

[ElvisStock]

If it can help determine between nerve pain caused by a disc and actual muscle pain, then it's a huge benefit to patients and doctors. I too have severe back pain, but the doctors have a difficult time determining what percentage of my pain is from my disc problem vs. what is coming from trigger points (muscle spasms). It's very frustrating as a patient because pain meds do not help with this kind of pain, at least in my case. With everything, you have to observe with caution, but I can see a great need for this device if it performs as advertised. GLTA!

[Black8]

Glad you were diagnosed and treated quickly. For many people, chronic pain is not so easily diagnosed. This market is in the billiins of dollars annually. Medicare and physicians are in need of a better diagnostic tool for these tougher cases. MPDD fills that need and could become as common as a stethoscope in medical offices. Back pain alone is a $100 billion market. Then there's the migraine market, the neck pain market and sports medicine.

IMHO, EPGL is massively undervalued. Scoop all you can here at these levels while the opportunity is here. EPGL needs only to achieve 1% the success of Medtronic to be an 80 cent stock. Place your bets.

EPGL STRONG BUY

[YogInvest]

I would not call it being naive. That person merely trusted the doctor's diagnosis and expertise.

There are cases where the origin of the pain is harder to determine and a lot of useless surgery happens because of that. The MPDD will not magically put an end to that very serious healthcare issue, but it will greatly enhance the quality of future diagnosis, which will be a great achievement in itself